Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review.
about
Treatment of drug-induced seizuresPropylene glycol-associated renal toxicity from lorazepam infusion.Issues in the management of acute agitation: how much current guidelines consider safety?Trimethoprim/Sulfamethoxazole-Induced Severe Lactic Acidosis: A Case Report and Review of the Literature.Pain in the ICU: a psychiatric perspective.Persistent lactic acidosis after chronic topical application of silver sulfadiazine in a pediatric burn patient: a review of the literature.Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation.Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole.Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital.Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity.A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients.Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations.Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.Drug-induced hyperlactatemia.
P2860
Q28387942-EAFEEF4F-C486-4A2A-8759-938F257C433FQ34267218-7D8F152F-E6DF-4A67-AAD6-DF00349E4B6EQ36821982-FDE71FCA-0F43-4084-9E18-AF53685CCCADQ37206421-20108A5E-29FB-483C-9373-50CA144A089AQ37974620-84F14394-6617-4886-A851-0A91A5DFC1D9Q38079591-BADCB0AF-D86C-4D16-90E6-B58228FB4A12Q39742685-4BF14AAB-078D-401C-92EE-46F0311FE8EAQ44606124-77684E37-0616-40AF-A3E3-0F6E56F36813Q46433399-069866B9-7F40-43D6-82C3-39EAB385648DQ46461320-B15CF43E-E8B4-4451-B8BD-F43DB91E8D4CQ46548480-4BD5CFCC-1CE6-43BB-BCC5-4000B903E448Q46701144-17DDEBF3-94CB-42FA-B3D2-3F4BEB48C7C1Q48612082-5C9146BE-590C-48BE-B2C9-A5003110AD23Q53797180-FDAD092E-1B60-4590-8465-1F6BD5E373E0
P2860
Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Short-term lorazepam infusion ...... icity: case report and review.
@ast
Short-term lorazepam infusion ...... icity: case report and review.
@en
Short-term lorazepam infusion ...... icity: case report and review.
@nl
type
label
Short-term lorazepam infusion ...... icity: case report and review.
@ast
Short-term lorazepam infusion ...... icity: case report and review.
@en
Short-term lorazepam infusion ...... icity: case report and review.
@nl
prefLabel
Short-term lorazepam infusion ...... icity: case report and review.
@ast
Short-term lorazepam infusion ...... icity: case report and review.
@en
Short-term lorazepam infusion ...... icity: case report and review.
@nl
P2860
P1433
P1476
Short-term lorazepam infusion ...... icity: case report and review.
@en
P2093
P2860
P304
P356
10.1592/PHCO.21.13.1140.34611
P407
P577
2001-09-01T00:00:00Z